Safety and Efficacy of GreenLight XPS Laser Vapoenucleation in Prostates Measuring over 150 mL

Journal of Endourology

Volumn 30, Issue 8, 2016, Pages 906-912

  Stone, Benjamin V ^a   Chughtai, Bilal ^a   Forde, James C ^a   Tam, Andrew W ^a   Lewicki, Patrick ^a   Te, Alexis E ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CATHETERIZATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; ENERGY; ENERGY DENSITY; ENERGY UTILIZATION; HUMAN; INDWELLING CATHETER; INTERNATIONAL PROSTATE SYMPTOM SCORE; LASER SURGERY; LENGTH OF STAY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTVOID RESIDUAL URINE VOLUME; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATE SIZE; PROSTATE SURGERY; QUALITY OF LIFE; RETREATMENT; TRANSRECTAL ULTRASONOGRAPHY; URINE FLOW RATE; URINE RETENTION; UROLOGICAL LASER SYSTEM; VAPOENUCLEATION; BLADDER CATHETERIZATION; BLOOD; COMPLICATION; LOW LEVEL LASER THERAPY; ORGAN SIZE; PATHOLOGY; PROCEDURES; PROSTATE; SAFETY; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; HUMANS; LASER THERAPY; LENGTH OF STAY; LOWER URINARY TRACT SYMPTOMS; MALE; OPERATIVE TIME; ORGAN SIZE; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; SAFETY; TIME FACTORS; TREATMENT OUTCOME; URINARY CATHETERIZATION; URINARY RETENTION;

EID: 84980021883     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2016.0288     Document Type: Article

References (28)

1. McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011;185:1793-1803.
2. Oelke M, Bachmann A, Descazeaud A, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2013;64:118-140.
3. Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010;58: 384-397.
4. Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 2008;53:160-166.
5. Gilling PJ, Kennett KM, Fraundorfer MR. Holmium laser enucleation of the prostate for glands larger than 100 g: An endourologic alternative to open prostatectomy. J Endourol 2000;14:529-531.
6. Placer J, Gelabert-Mas A, Vallmanya F, et al. Holmium laser enucleation of prostate: Outcome and complications of self-taught learning curve. Urology 2009;73:1042-1048.
7. Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180W GreenLightXPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol 2015; 193:570-578.
8. Thomas JA, Tubaro A, Barber N, et al. A Multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: Two-yr outcomes of the GOLIATH study. Eur Urol 2016;69:94-102.
9. Alivizatos G, Skolarikos A, Chalikopoulos D, et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study. Eur Urol 2008;54:427-437.
10. Gu X, Vricella GJ, Spaliviero M, Wong C. Does size really matter? The impact of prostate volume on the efficacy and safety of GreenLight HPS laser photoselective vaporization of the prostate. J Endourol 2012;26:525-530.
11. Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 2007;100:593-598.
12. Woo HH. Photoselective vaporization of the prostate using the 120-W lithium triborate laser in enlarged prostates (>120 cc). BJU Int 2011;108:860-863.
13. Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: A short-term prospective randomized trial. Urology 2008;71:247-251.
14. Elmansy H, Baazeem A, Kotb A, et al. Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60ml: Preliminary results of a prospective, randomized clinical trial. J Urol 2012;188:216-221.
15. Stone BV, Chughtai B, Kaplan SA, Te AE, Lee RK. GreenLight laser for prostates over 100 ml: What is the evidence? Curr Opin Urol 2016;26:28-34.
16. Elterman DS, Chughtai B, Lee R, et al. Comparison of techniques for transurethral laser prostatectomy: Standard photoselective vaporization of the prostate versus transurethral laser enucleation of the prostate. J Endourol 2013; 27:751-755.
17. Hueber PA, Bienz MN, Valdivieso R, et al. Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 watt system: Multicenter study of the impact of prostate size on safety and outcomes. J Urol 2015;194: 462-469.
18. Lebdai S, Prezelin Y, Pereira H, Bruyere F. Prostatespecific antigen evolution after photoselective vaporization of the prostate. J Endourol 2014;28:347-352.
19. Jones P, Alzweri L, Rai BP, Somani BK, Bates C, Aboumarzouk OM. Holmium laser enucleation versus simple prostatectomy for treating large prostates: Results of a systematic reviewandmeta-analysis. Arab JUrol 2016;14:50-58.
20. Naspro R, Suardi N, SaloniaA, et al.Holmiumlaser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 2006;50:563-568.
21. Altay B, Erkurt B, Kiremit MC, Guzelburc V, Boz MY, Albayrak S. 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci 2015; 30:317-323.
22. Emara AM, Barber NJ. The continuous evolution of the Greenlight laser; the XPS generator and the MoXy laser fiber, expanding the indications for photoselective vaporization of the prostate. J Endourol 2014;28:73-78.
23. West KE, Woo HH. Does prostate size impact upon perioperative outcomes associated with photoselective vaporization of the prostate using the 180W lithium triborate laser? Urol Ann 2015;7:17-20.
24. Nam JK, Kim HW, Lee DH, Han J-Y, Lee JZ, Park S-W. Risk factors for transient urinary incontinence after holmium laser enucleation of the prostate. World J Mens Health 2015;33:88-94.
25. Salonia A, Suardi N, Naspro R, et al. Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: An inpatient cost analysis. Urology 2006;68: 302-306.
26. Hueber PA, Ben-Zvi T, Liberman D, et al. Mid term outcomes of initial 250 case experience with GreenLight 120W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: Comparison of prostate volumes <60 cc, 60 cc-100 cc and >100 cc. Can J Urol 2012; 19:6450-6458.
27. Tasci AI, Ilbey YO, Luleci H, et al. 120-W GreenLight laser photoselective vaporization of prostate for benign prostatic hyperplasia: Midterm outcomes. Urology 2011; 78:134-140.
28. Ben-Zvi T, Hueber PA, Liberman D, Valdivieso R, Zorn KC. GreenLight XPS 180Wvs HPS 120Wlaser therapy for benign prostate hyperplasia: A prospective comparative analysis after 200 cases in a single-center study. Urology 2013;81:853-858.